A carregar...
BCMA-Targeting Therapy: Driving a New Era of Immunotherapy in Multiple Myeloma
The treatment of multiple myeloma (MM) has entered into a new era of immunotherapy. Novel immunotherapies will significantly improve patient outcome via simultaneously targeting malignant plasma cell (PC) and reversing immunocompromised bone marrow (BM) microenvironment. B-cell maturation antigen (B...
Na minha lista:
| Publicado no: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7352710/ https://ncbi.nlm.nih.gov/pubmed/32516895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12061473 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|